TCN-213
TCN-213 je antagonist NMDA receptora.[3]
![2-[[5-(benzilamino)-1,3,4-tiadiazol-2-il]sulfanil]-N-(cikloheksilmetil)acetamid](/wiki/%D0%94%D0%B0%D1%82%D0%BE%D1%82%D0%B5%D0%BA%D0%B0:TCN-213.png)
| |
| Nazivi | |
|---|---|
| IUPAC naziv
2-[[5-(benzilamino)-1,3,4-tiadiazol-2-il]sulfanil]-N-(cikloheksilmetil)acetamid
| |
Drugi nazivi
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C18H24N4OS2 | |
| Molarna masa | 376,54 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Reference уреди
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.
